Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021

Despite belonging to a relatively new class of pharmaceuticals, biological drugs have been used since the 1980s, when they brought about a breakthrough in the treatment of chronic diseases, especially cancer. They conquered a large space in the pipeline of the pharmaceutical industry and boosted the...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Alexander C., Oshiro, Mariana Y., Albericio, Fernando, de la Torre, Beatriz G., Pereira, Gustavo José V., Gonzaga, Rodrigo V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496574/
https://www.ncbi.nlm.nih.gov/pubmed/36140426
http://dx.doi.org/10.3390/biomedicines10092325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496574/
https://www.ncbi.nlm.nih.gov/pubmed/36140426
http://dx.doi.org/10.3390/biomedicines10092325

Ejemplares similares